Chemed Corporation (NYSE: CHE) reported Q3 EPS of $1.73, $0.09 worse than the analyst estimate of $1.82. Revenue for the quarter came in at $393 million versus the consensus estimate of $396.97 million.

GUIDANCE:

Chemed Corporation sees FY2016 EPS of $7.23-$7.30, versus the consensus of $7.25.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.